Furthermore, the expression of CUEDC2 was strongly correlated with the tumor T classification (P = 0.001) and clinical stage (P = 0.002) of patients with lung adenocarcinoma (Supplementary Table S1). This evidence concerns the gene CUEDC2 and lung adenocarcinoma.